Pharmacological Preconditioning With Hyperbaric Oxygen: Can This Therapy Attenuate Myocardial Ischemic Reperfusion Injury and Induce Myocardial Protection via Nitric Oxide?

Journal of Surgical Research

Volumn 149, Issue 1, 2008, Pages 155-164

  Yogaratnam, Jeysen Zivan ^a   Laden, Gerard ^b   Guvendik, Lavent ^a   Cowen, Mike ^a   Cale, Alex ^a   Griffin, Steve ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b Classic Hospital   (United Kingdom)

Author keywords

hyperbaric oxygen; ischemic reperfusion injury; myocardial protection; nitric oxide

Indexed keywords

ALTEPLASE; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANYLATE CYCLASE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; PEROXYNITRITE; S NITROSOTHIOL;

CORONARY ARTERY DILATATION; DRUG MECHANISM; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; HYPERBARIC OXYGEN; HYPEROXIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TREATMENT RESPONSE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CARDIAC SURGICAL PROCEDURES; HUMANS; HYPERBARIC OXYGENATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; RATS;

EID: 48949101711     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.09.003     Document Type: Review

References (125)

1. Bolli R., Becker L., Gross G., et al. Myocardial protection at a crossroads: The need for translation into clinical therapy. Circ Res 95 (2004) 125
2. Hearse D.J. Cardioplegia: The protection of the myocardium during open heart surgery: A review. J Physiol (Paris) 76 (1980) 751
3. Hearse D.J., Garlick P.B., and Humphrey S.M. Ischemic contracture of the myocardium: Mechanisms and prevention. Am J Cardiol 39 (1977) 986
4. McCully J.D., Tsukube T., Ataka K., et al. Myocardial cytosolic calcium accumulation during ischemia/reperfusion: The effects of aging and cardioplegia. J Card Surg 9 (1994) 449
5. Matsuda H., McCully J.D., and Levitsky S. Developmental differences in cytosolic calcium accumulation associated with global ischemia: Evidence for differential intracellular calcium channel receptor activity. Circulation 96 (1997) II-233 Discussion II-238
6. Mangano D.T. Cardiovascular morbidity and CABG surgery-a perspective: Epidemiology, costs, and potential therapeutic solutions. J Card Surg 10 (1995) 366
7. Ferguson Jr. T.B., Hammill B.G., Peterson E.D., et al. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: A report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73 (2002) 480 Discussion 489
8. Peterson E.D., Coombs L.P., Ferguson T.B., et al. Hospital variability in length of stay after coronary artery bypass surgery: Results from the Society of Thoracic Surgeon's National Cardiac Database. Ann Thorac Surg 74 (2002) 464
9. Association AH. 2002 Heart and Stroke Statistical Update (2002), American Heart Association, Dallas
10. Kloner R.A., and Rezkalla S.H. Cardiac protection during acute myocardial infarction: Where do we stand in 2004?. J Am Coll Cardiol 44 (2004) 276
11. Birdi I., Chaudhuri N., Lenthall K., et al. Emergency reinstitution of cardiopulmonary bypass following cardiac surgery: Outcome justifies the cost. Eur J Cardiothorac Surg 17 (2000) 743
12. Koppenol W.H. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radical Biol Med 25 (1998) 385
13. Tuteja N., Chandra M., Tuteja R., et al. Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology. J Biomed Biotechnol 2004 (2004) 227
14. Forstermann U., Closs E.I., Pollock J.S., et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23 (1994) 1121
15. Xuan Y.T., Tang X.L., Qiu Y., et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 279 (2000) H2360
16. Massion P.B., Pelat M., Belge C., et al. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A Mol Integr Physiol 142 (2005) 144
17. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J Mol Cell Cardiol 33 (2001) 1897
18. Lefer A.M., Campbell B., Shin Y.K., et al. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 100 (1999) 178
19. Asanuma H., Kitakaze M., Funaya H., et al. Nifedipine limits infarct size via NO-dependent mechanisms in dogs. Basic Res Cardiol 96 (2001) 497
20. Hartman J.C., Kurc G.M., Hullinger T.G., et al. Inhibition of nitric oxide synthase prevents myocardial protection by ramipril. J Pharmacol Exp Ther 270 (1994) 1071
21. Hafezi-Moghadam A., Simoncini T., Yang Z., et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nat Med 8 (2002) 473
22. Schulz R., Cohen M.V., Behrends M., et al. Signal transduction of ischemic preconditioning. Cardiovasc Res 52 (2001) 181
23. Bolli R. The late phase of preconditioning. Circ Res 87 (2000) 972
24. McGowan Jr. F.X., Davis P.J., del Nido P.J., et al. Endothelium-dependent regulation of coronary tone in the neonatal pig. Anesth Analg 79 (1994) 1094
25. Kubes P., and Granger D.N. Nitric oxide modulates microvascular permeability. Am J Physiol 262 (1992) H611
26. Noel A.A., Fallek S.R., Hobson II R.W., et al. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation. J Vasc Surg 22 (1995) 661 Discussion 669
27. Radomski M.W., Palmer R.M., and Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin in platelets. Br J Pharmacol 92 (1987) 181
28. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43 (1999) 860
29. Conger J.D., and Weil J.V. Abnormal vascular function following ischemia-reperfusion injury. J Investig Med 43 (1995) 431
30. Ronson R.S., Nakamura M., and Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 44 (1999) 47
31. Johnson III G., Tsao P.S., Mulloy D., et al. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 252 (1990) 35
32. Sato H., Zhao Z.Q., and Vinten-Johansen J. L-Arginine inhibits neutrophil adherence and coronary artery dysfunction. Cardiovasc Res 31 (1996) 63
33. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88 (1991) 4651
34. Clancy R.M., Leszczynska-Piziak J., and Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90 (1992) 1116
35. Ohashi Y., Kawashima S., Hirata K., et al. Nitric oxide inhibits neutrophil adhesion to cytokine-activated cardiac myocytes. Am J Physiol 272 (1997) H2807
36. De Caterina R., Libby P., Peng H.B., et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96 (1995) 60
37. Finkel M.S., Oddis C.V., Jacob T.D., et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992) 387
38. Trochu J.N., Bouhour J.B., Kaley G., et al. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: Implications in health and disease. Circ Res 87 (2000) 1108
39. Paulus W.J., Frantz S., and Kelly R.A. Nitric oxide and cardiac contractility in human heart failure: Time for reappraisal. Circulation 104 (2001) 2260
40. Xie Y.W., Shen W., Zhao G., et al. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res 79 (1996) 381
41. Paulus W.J., Vantrimpont P.J., and Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89 (1994) 2070
42. Schlesinger M.J. Heat shock proteins: The search for functions. J Cell Biol 103 (1986) 321
43. Ang D., Liberek K., Skowyra D., et al. Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem 266 (1991) 24233
44. Zingarelli B., Hake P.W., Yang Z., et al. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-κB and AP-1 activation and enhances myocardial damage. FASEB J 16 (2002) 327
45. Latchman D.S. Heat shock proteins and cardiac protection. Cardiovasc Res 51 (2001) 637
46. Kim Y.M., de Vera M.E., Watkins S.C., et al. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272 (1997) 1402
47. Li W., Jia G., Guo W., et al. Nitric oxide opens second window of protection in ischemic preconditioning via induction of heat-shock protein 72. Chin Med J (Engl) 116 (2003) 258
48. Brady A.J., Warren J.B., Poole-Wilson P.A., et al. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265 (1993) H176
49. Mittal C.K. Guanylate Cyclase: Regulation of cyclic GMP metabolism. Cyclic nucleotides. 1. MF. In: Nathanson J.A., and Kebabian J.W. (Eds) (1982), Springer, Berlin/Heidelberg/New York
50. Mery P.F., Pavoine C., Belhassen L., et al. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268 (1993) 26286
51. Han X., Kobzik L., Balligand J.L., et al. Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells. Circ Res 78 (1996) 998
52. Ji G.J., Fleischmann B.K., Bloch W., et al. Regulation of the L-type Ca2+ channel during cardiomyogenesis: Switch from NO to adenylyl cyclase-mediated inhibition. FASEB J 13 (1999) 313
53. Jennings R.B., and Reimer K.A. The cell biology of acute myocardial ischemia. Annu Rev Med 42 (1991) 225
54. Rakhit R.D., Mojet M.H., Marber M.S., et al. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation 103 (2001) 2617
55. Nakanishi K., Vinten-Johansen J., Lefer D.J., et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 263 (1992) H1650
56. Lefer D.J., Nakanishi K., Vinten-Johansen J., et al. Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. Am J Physiol 263 (1992) H850
57. Weyrich A.S., Ma X.L., and Lefer A.M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86 (1992) 279
58. Amrani M., Chester A.H., Jayakumar J., et al. L-arginine reverses low coronary reflow and enhances postischemic recovery of cardiac mechanical function. Cardiovasc Res 30 (1995) 200
59. Xia Y., and Zweier J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94 (1997) 6954
60. Xia Y., Dawson V.L., Dawson T.M., et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93 (1996) 6770
61. Beckman J. The physiological and pathological chemistry of nitric oxide, nitric oxide principles, and actions. In: Lancaster J.J. (Ed) (1996), Academic Press, San Diego 1
62. Beckman J.S., and Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 21 (1993) 330
63. Liu S., Beckman J.S., and Ku D.D. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J Pharmacol Exp Ther 268 (1994) 1114
64. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 271 (1996) C1424
65. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9 (1996) 836
66. Lefer D.J., Scalia R., Campbell B., et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 99 (1997) 684
67. Nossuli T.O., Hayward R., Jensen D., et al. Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol 275 (1998) H509
68. Nossuli T.O., Hayward R., Scalia R., et al. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation 96 (1997) 2317
69. Liu P., Yin K., Nagele R., et al. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. J Pharmacol Exp Ther 284 (1998) 1139
70. Liu P., Xu B., Quilley J., et al. Peroxynitrite attenuates hepatic ischemia-reperfusion injury. Am J Physiol Cell Physiol 279 (2000) C1970
71. Ku D.D., Liu S., and Dai J. Coronary vascular and antiplatelet effects of peroxynitrite in human tissues. Endothelium 3 (1995) 309
72. Naseem K.M., and Bruckdorfer K.R. Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets. Biochem J 310 Pt 1 (1995) 149
73. Wu M., Pritchard Jr. K.A., Kaminski P.M., et al. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol 266 (1994) H2108
74. Foresti R., Clark J.E., Green C.J., et al. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J Biol Chem 272 (1997) 18411
75. Moro M.A., Darley-Usmar V.M., Goodwin D.A., et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 91 (1994) 6702
76. Gaston B., Reilly J., Drazen J.M., et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 90 (1993) 10957
77. Langford E.J., Brown A.S., Wainwright R.J., et al. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet 344 (1994) 1458
78. Ignarro L.J., Lippton H., Edwards J.C., et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218 (1981) 739
79. Delyani J.A., Nossuli T.O., Scalia R., et al. S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: Role of the endothelium. J Pharmacol Exp Ther 279 (1996) 1174
80. Davidson C.A., Kaminski P.M., and Wolin M.S. NO elicits prolonged relaxation of bovine pulmonary arteries via endogenous peroxynitrite generation. Am J Physiol 273 (1997) L437
81. Stamler J.S., Jaraki O., Osborne J., et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89 (1992) 7674
82. Mayer B., Schrammel A., Klatt P., et al. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem 270 (1995) 17355
83. Cabigas B.P., Su J., Hutchins W., et al. Hyperoxic and hyperbaric-induced cardioprotection: Role of nitric oxide synthase 3. Cardiovasc Res 72 (2006) 143
84. Buras J.A., Stahl G.L., Svoboda K.K., et al. Hyperbaric oxygen down-regulates ICAM-1 expression induced by hypoxia and hypoglycemia: The role of NOS. Am J Physiol Cell Physiol 278 (2000) C292
85. Russwurm M., and Koesling D. NO activation of guanylyl cyclase. EMBO J 23 (2004) 4443
86. Thom S.R., Mendiguren I., Hardy K., et al. Inhibition of human neutrophil beta2-integrin-dependent adherence by hyperbaric O2. Am J Physiol 272 (1997) C770
87. Chen Q., Banick P.D., and Thom S.R. Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis. J Pharmacol Exp Ther 276 (1996) 929
88. Malik A.B., and Lo S.K. Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol Rev 48 (1996) 213
89. Zamboni W.A., Roth A.C., Russell R.C., et al. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 91 (1993) 1110
90. Banick P.D., Chen Q., Xu Y.A., et al. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J Cell Physiol 172 (1997) 12
91. Lefer A.M., and Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32 (1996) 743
92. Pryor W.A., and Squadrito G.L. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 268 (1995) L699
93. Rubanyi G.M., Ho E.H., Cantor E.H., et al. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 181 (1991) 1392
94. Benedetti S., Lamorgese A., Piersantelli M., et al. Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem 37 (2004) 312
95. Gregorevic P., Lynch G.S., and Williams D.A. Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles. Eur J Appl Physiol 86 (2001) 24
96. Conconi M.T., Baiguera S., Guidolin D., et al. Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. J Investig Med 51 (2003) 227
97. Sterling D.L., Thornton J.D., Swafford A., et al. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 88 (1993) 1931
98. Nylander G., Nordstrom H., Lewis D., et al. Metabolic effects of hyperbaric oxygen in postischemic muscle. Plast Reconstr Surg 79 (1987) 91
99. Yamada T., Taguchi T., Hirata Y., et al. The protective effect of hyperbaric oxygenation on the small intestine in ischemia-reperfusion injury. J Pediatr Surg 30 (1995) 786
100. Chen M.F., Chen H.M., Ueng S.W., et al. Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury. Liver 18 (1998) 110
101. Lebuffe G., Schumacker P.T., Shao Z.H., et al. ROS and NO trigger early preconditioning: Relationship to mitochondrial KATP channel. Am J Physiol Heart Circ Physiol 284 (2003) H299
102. Atochin D.N., Fisher D., Demchenko I.T., et al. Neutrophil sequestration and the effect of hyperbaric oxygen in a rat model of temporary middle cerebral artery occlusion. Undersea Hyperb Med 27 (2000) 185
103. Dekleva M., Neskovic A., Vlahovic A., et al. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. Am Heart J 148 (2004) E14
104. Vlahovic A., Neskovic A.N., Dekleva M., et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. Am Heart J 148 (2004) e1
105. Shandling A.H., Ellestad M.H., Hart G.B., et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The "HOT MI" pilot study. Am Heart J 134 (1997) 544
106. Stavitsky Y., Shandling A.H., Ellestad M.H., et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The "HOT MI" randomized multicenter study. Cardiology 90 (1998) 131
107. Thurston J.G., Greenwood T.W., Bending M.R., et al. A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Q J Med 42 (1973) 751
108. Sharifi M., Fares W., Abdel-Karim I., et al. Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. Am J Cardiol 93 (2004) 1533
109. Cohen M.V., Yang X.M., and Downey J.M. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70 (2006) 231
110. Lopez-Ongil S., Hernandez-Perera O., Navarro-Antolin J., et al. Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 124 (1998) 447
111. Hatanaka Y., Fujii J., Fukutomi T., et al. Reactive oxygen species enhances the induction of inducible nitric oxide synthase by sphingomyelinase in RAW264.7 cells. Biochim Biophys Acta 1393 (1998) 203
112. Drummond G.R., Cai H., Davis M.E., et al. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86 (2000) 347
113. Mathy-Hartert M., Deby-Dupont G.P., Reginster J.Y., et al. Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes. Osteoarthritis Cartilage 10 (2002) 547
114. Whorton A.R., Simonds D.B., and Piantadosi C.A. Regulation of nitric oxide synthesis by oxygen in vascular endothelial cells. Am J Physiol 272 (1997) L1161
115. Elayan I.M., Axley M.J., Prasad P.V., et al. Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain. J Neurophysiol 83 (2000) 2022
116. Thom S.R., Fisher D., Zhang J., et al. Stimulation of perivascular nitric oxide synthesis by oxygen. Am J Physiol Heart Circ Physiol 284 (2003) H1230
117. Jimenez A.H., Tanner M.A., Caldwell W.M., et al. Effects of oxygen tension on flow-induced vasodilation in porcine coronary resistance arterioles. Microvasc Res 51 (1996) 365
118. Tjarnstrom J., Holmdahl L., Falk P., et al. Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation. Scand J Clin Lab Invest 61 (2001) 539
119. Hong J.P., Kwon H., Chung Y.K., et al. The effect of hyperbaric oxygen on ischemia-reperfusion injury: An experimental study in a rat musculocutaneous flap. Ann Plast Surg 51 (2003) 478
120. Engler R.L., Dahlgren M.D., Morris D.D., et al. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 251 (1986) H314
121. Sirsjo A., Lehr H.A., Nolte D., et al. Hyperbaric oxygen treatment enhances the recovery of blood flow and functional capillary density in postischemic striated muscle. Circ Shock 40 (1993) 9
122. Thom S.R., Bhopale V.M., Velazquez O.C., et al. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol 290 (2006) H1378
123. Al-Waili N.S., Butler G.J., Beale J., et al. Hyperbaric oxygen and malignancies: A potential role in radiotherapy, chemotherapy, tumor surgery, and phototherapy. Med Sci Monit 11 (2005) RA279
124. Schabitz W.R., Schade H., Heiland S., et al. Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Stroke 35 (2004) 1175
125. Vila J.F., Balcarce P.E., Abiusi G.R., et al. Improvement in motor and cognitive impairment after hyperbaric oxygen therapy in a selected group of patients with cerebrovascular disease: A prospective single-blind controlled trial. Undersea Hyperb Med 32 (2005) 341